PRAUSNITZ MARK R.,EDELHAUSER HENRY F.,PATEL SAMIRKUMAR RAJNIKANT
申请号：
NZ60318511
公开号：
NZ603185A
申请日:
2011.04.26
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
603185 Disclosed is the use of a fluid drug formulation in the manufacture of a medicament for the treatment of an ocular disorder, wherein the medicament is formulated to be delivered via a hollow microneedle inserted into the sclera, the microneedle having a tip end with an opening, wherein the medicament is formulated for being infused over a period of time through the inserted microneedle and into the suprachoroidal space of the eye, wherein during the period the infused medicament is formulated to flow within the suprachoroidal space away from the insertion site.
